Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1144143.RAkMZxnHFmU2NPjTsl2Di_YWIcpadj2mdgWU6nq-igJow130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1144143.RAkMZxnHFmU2NPjTsl2Di_YWIcpadj2mdgWU6nq-igJow130_assertion type Assertion NP1144143.RAkMZxnHFmU2NPjTsl2Di_YWIcpadj2mdgWU6nq-igJow130_head.
- NP1144143.RAkMZxnHFmU2NPjTsl2Di_YWIcpadj2mdgWU6nq-igJow130_assertion wasGeneratedBy ECO_0000203 NP1144143.RAkMZxnHFmU2NPjTsl2Di_YWIcpadj2mdgWU6nq-igJow130_provenance.
- NP1144143.RAkMZxnHFmU2NPjTsl2Di_YWIcpadj2mdgWU6nq-igJow130_assertion wasDerivedFrom befree-2016 NP1144143.RAkMZxnHFmU2NPjTsl2Di_YWIcpadj2mdgWU6nq-igJow130_provenance.
- NP1144143.RAkMZxnHFmU2NPjTsl2Di_YWIcpadj2mdgWU6nq-igJow130_assertion SIO_000772 24413734 NP1144143.RAkMZxnHFmU2NPjTsl2Di_YWIcpadj2mdgWU6nq-igJow130_provenance.
- NP1144143.RAkMZxnHFmU2NPjTsl2Di_YWIcpadj2mdgWU6nq-igJow130_assertion evidence source_evidence_literature NP1144143.RAkMZxnHFmU2NPjTsl2Di_YWIcpadj2mdgWU6nq-igJow130_provenance.
- NP1144143.RAkMZxnHFmU2NPjTsl2Di_YWIcpadj2mdgWU6nq-igJow130_assertion description "[These analyses identified highly recurrent epigenetic factor mutations in TET2, DNMT3A and IDH2 as well as a new highly prevalent RHOA mutation encoding a p.Gly17Val alteration present in 22 of 35 (67%) angioimmunoblastic T cell lymphoma (AITL) samples and in 8 of 44 (18%) PTCL, not otherwise specified (PTCL-NOS) samples.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1144143.RAkMZxnHFmU2NPjTsl2Di_YWIcpadj2mdgWU6nq-igJow130_provenance.